The tumour suppressor gene product, p53, is involved in mediating cellular responses to DNA damage including growth arrest and/or apoptosis. The mechanism by which p53 protein senses the presence of damaged DNA is not understood. The possibility that p53 may be posttranslationally modi®ed by enzymes that are activated in response to DNA damage including DNA-dependent protein kinase (DNA-PK), poly(ADP-ribose) polymerase and stress activated protein kinase has received considerable attention. Recent studies have indicated that DNA-PK is not required for the transactivation or apoptosis-promoting activities of p53 protein. However, the possibility that other functions of p53 may be dependent on phosphorylation by DNA-PK has not been explored. Here we describe a series of experiments that compares the expression, function and phosphorylation status of p53 protein in normal and DNA-PK-de®cient scid cells. While several novel p53 phosphoforms are generated in response to DNA damage in normal cells, the same phosphoforms are observed in scid cells.
Introduction p53 protein plays a critical role in determining the cellular response to stress. DNA strand breaks, produced by g-irradiation or by DNA repair intermediates following treatment with UV irradiation or chemotherapeutic agents, result in the accumulation of p53 protein and in the activation of its transcriptional activity (Levine, 1997) . The rapid and transient upregulation of p53 protein is mediated through a posttranscriptional mechanism involving increased translation (Mosner et al., 1995; Fu and Benchimol, 1997) and increased protein stability (Maltzman and Czyzyk, 1984) . In addition, post-translational modi®cation of p53 protein appears necessary to activate the latent sequence-speci®c DNA binding and transactivation functions of p53 (Hupp et al., 1992; Jayaraman and Prives, 1995) . The activation of p53 protein following DNA damage can result in p53-dependent cell cycle arrest in G1 or in p53-dependent apoptosis depending on cell type or culture conditions (Bates and Vousden, 1996; Levine, 1997) . How p53 becomes activated in response to broken DNA is unknown. One model proposes that cellular proteins, that respond to the presence of broken DNA ends, interact with p53 protein and promote its activation through phosphorylation or other activation signals (Anderson, 1994) . Attractive candidates include DNA-dependent protein kinase (DNA-PK), ATM protein, stress activated protein kinase (SAPK) and poly(ADP-ribose) polymerase (PARP).
p53 protein is phosphorylated at several serine and threonine sites in vivo. Experiments performed in vitro indicate that p53 protein can be phosphorylated on multiple sites by a variety of kinases (reviewed in Meek, 1994; Steegenga et al., 1996) . The kinases responsible for phosphorylating p53 in vivo, however, remain unknown. A number of studies have indicated that p53 protein is phosphorylated in response to stress and two recent studies have identi®ed speci®c serine residues at the N-terminus of p53 that are phosphorylated in response to DNA damage. Phosphorylation at serine 15 results in dissociation of bound MDM2 protein and stabilization of p53 (Shieh et al., 1997; Siliciano et al., 1997) . However, the signi®cance of p53 protein phosphorylation with regards to tumour suppression and growth suppression remains unclear with many contradictory reports claiming or dismissing a role for phosphorylation in modulating p53 protein function (Milne et al., 1992; Fiscella et al., 1993 Fiscella et al., , 1994 Fuchs et al., 1995; Mayr et al., 1995; Hall et al., 1996; Hao et al., 1996) . This is further complicated by the fact that protein phosphorylation is commonly investigated by the procedure of metabolic labelling with 32 P-orthophosphate. Exposure to radioactive isotopes leads to stress-induction of p53 by virtue of radiation damage from radioisotope decay (Dover et al., 1994; Yeargin and Haas, 1995) , or perhaps through the metabolic labelling procedure itself. As a result, phosphorylation of p53 cannot be assessed accurately using isotopic procedures.
In the presence of DNA, DNA-PK exhibits serine/ threonine protein kinase activity and phosphorylates many cellular proteins in vitro including p53 protein (Lees-Miller et al., 1992; Anderson, 1993; Wu et al., 1993; Mayo et al., 1997) . DNA-PK consists of a catalytic subunit (DNA-PK CS ) and a DNA-binding heterodimer (Ku) consisting of Ku70 and Ku80 subunits (Hartley et al., 1995) . Previous studies using cells obtained from scid mice that are de®cient in DNA-PK activity as the result of a mutation in the gene encoding DNA-PK CS demonstrated that the ability of p53 protein to promote cell cycle arrest or apoptosis was preserved in these cells Rathmell et al., 1997; Bogue et al., 1996) . It remains possible, however, that other, less well characterized functions of p53 protein (binding to cellular proteins, exonuclease activity, strand renaturation activity) may be compromised in DNA-PK de®cient cells.
In this paper, we use a non-radioactive assay to examine and compare the changes in p53 protein phosphorylation that occur in normal and scid cells in response to g-irradiation. Our results indicate that novel p53 phosphoforms appear in irradiated cells and that the pattern of these phosphoforms is identical in normal and scid cells.
Results
Similar levels of p53 protein in g-irradiated kidney cells from BALB/c and scid mice To determine if DNA-PK plays a role in the accumulation of p53 protein after g-irradiation, we established primary cell cultures from the kidneys of BALB/c and scid mice. Similar amounts of p53 protein were present in these cultures prior to irradiation and a comparable increase was observed after irradiation ( Figure 1 ). In a time-course experiment, we observed that the kinetics and extent of p53 protein accumulation, and the subsequent restoration of starting levels were similar in the BALB/c and scid kidney cell cultures (Figure 2 ). We conclude that the basal level of p53 protein is similar in BALB/c and scid kidney cell cultures and that p53 protein accumulation after girradiation occurs normally in scid kidney cells.
BALB/c and scid kidney cells undergo p53-dependent cell cycle arrest in response to g-irradiation
The ability of cells to undergo cell cycle arrest in G1 following g-irradiation is known to be controlled primarily through the action of p53. To determine if this function of p53 was intact in scid cells, we performed a¯ow cytometric analysis of irradiated BALB/c and scid kidney cells. Kidney cells were also prepared from p53 null mice and were used to demonstrate the dependency of G1 arrest on p53. The results presented in Figure 3 show that scid cells, like BALB/c cells, undergo G1 cell cycle arrest in response to g-irradiation, while the p53 7/7 cells exhibited a greatly diminished response to irradiation. We conclude that scid cells retain the ability to undergo p53-dependent cell cycle arrest in response to DNA damage. This result is consistent with previously published results Rathmell et al., 1997; Bogue et al., 1996) . The kidney cells showed no signs of apoptosis or death following exposure to 6 Gy as ascertained by the lack of signi®cant hypodiploidy on¯ow cytometry and by the absence of cells losing adherence and lifting o the tissue culture plates. Hence, it is likely that these cells undergo permanent cell cycle arrest after irradiation.
Analysis of phosphoforms of p53 protein in BALB/c and scid kidney cells
Since scid cells exhibit normal p53-mediated G1 arrest after g-irradiation, it is unlikely that phosphorylation of p53 by DNA-PK is required for the transactivation activity of p53. However, it remains possible that p53 is a physiological substrate of DNA-PK and that phosphorylation aects other properties of p53. To address this possibility, we performed an analysis of p53 protein isoforms by two-dimensional gel electrophoresis. Although this procedure has limitations with respect to sensitivity and inability to identify speci®c phosphorylated residues, it does provide information on the number of dierent phosphoforms within a population of molecules and reveals changes in the phosphorylation status of a protein. p53 protein was immunoprecipitated from BALB/c and scid kidney cells 2 h after exposure to 6 Gy g-irradiation. Nonirradiated cells served as controls. Following immunoprecipitation and collection onto Protein G-Sepharose beads, the samples were subjected to isoelectric focusing in the ®rst dimension and SDS-polyacrylamide gel electrophoresis in the second dimension to Figure 1 Western blot analysis of p53 protein expressed in irradiated BALB/c, scid and p537/7 primary kidney cells. Extracts were prepared from cells either left untreated (7) or 2 h after treatment with a dose of 6 Gy of ionizing radiation (+IR). 1.55 mg of total protein from each sample was used for immunoprecipitation with monoclonal anti-p53 antibody, PAb246. Following SDS ± PAGE and transfer to PVDF membrane, binding of polyclonal antibody PAb7 to p53 was detected using species-adsorbed anti-sheep IgG antibodies complexed to horseradish peroxidase (HRP) (Chemicon) and chemiluminescence Figure 2 Kinetics of p53 protein accumulation following girradiation of primary kidney cells prepared from BALB/c and scid mice. The plot displays the densitometric scan of a Western blot. Extracts were prepared from 10 5 kidney cells at dierent times after irradiation and proteins were resolved by gel electrophoresis. p53 protein was detected by Western blotting and visualized by chemiluminescence resolve proteins on the basis of charge and molecular weight, respectively. Following protein transfer to PVDF membranes, the p53 isoforms were identi®ed by immuno-blotting with polyclonal antibodies to p53 protein. Initial analysis of p53 protein from BALB/c mice ( Figure 4 ) showed a predominant basic form before irradiation, and at least ®ve novel isoforms following irradiation. To determine whether these novel, radiation-induced isoforms represented phosphoforms, the samples were treated with l phosphatase prior to analysis by two-dimensional gel electrophoresis. All of the novel isoforms were l phosphatasesensitive and collapsed into one basic form indicating that they represented phosphoforms. Using ampholyte gradients that gave better separation, we observed similar p53 phosphoforms in the non-irradiated BALB/ c and scid kidney cells ( Figure 5 ). Moreover, we detected the appearance of similar, novel phosphoforms following irradiation of BALB/c and scid kidney cells. The striking similarity in response exhibited by BALB/c and scid cells suggests that DNA-PK is unlikely to be responsible for promoting phosphorylation of p53 in cells that have undergone DNA damage.
Elevated steady state level of p53 protein in the scid thymus Two previous studies reported ®nding higher levels of p53 protein in scid thymocytes than in normal thymocytes (Guidos et al., 1996; Nacht et al., 1996) . Higher levels of p53 protein were detected in scid thymocytes but not in scid splenocytes (primarily myeloid cells) suggesting that the thymocyte-speci®c up-regulation of p53 protein could be the result of V(D)J-speci®c double-stranded DNA breaks that accumulate in these cells. To investigate this further, we measured p53 protein levels in thymocytes derived from BALB/c mice, from scid mice and from F1 hybrid mice.
Since the cellularity of the thymus in scid mice is about 10 5 cells, much too small for biochemical analysis such as Westerns, we used a T-cell receptor (TCR) transgenic scid mouse, Ova-scid (Spaner, 1994) , to partially restore lymphocyte development and to permit examination of p53 protein expression in scid thymocytes. The functionally rearranged TCRab transgenes encode a TCR directed against amino acids 323 ± 329 of chicken ovalbumin presented by IA d . The TCRab transgenes do not interfere with the inherent scid defect of the thymus; the thymocytes remain radiosensitive and incompetent at completing V(D)J recombination. BALB/c mice were mated to Ova-scid to produce F1 ospring (Ova-scid/+). The F1 mice are heterozygous at the DNA-PK CS locus with Figure 3 Flow cytometric assessment of the G1/S arrest in BALB/c, scid and p537/7 primary kidney cells. Cells were irradiated with a dose of 6 Gy and harvested for cell cycle analysis 24 h following irradiation. Each bar represents the mean obtained from two independent experiments. The error bars represent one standard deviation Figure 4 Analysis of p53 phosphoforms by two-dimensional gel electrophoresis. BALB/c kidney cells were lysed 2 h after girradiation (6 Gy). p53 protein was enriched by immunoprecipitation prior to isoelectric focussing in the ®rst dimension and SDSpolyacrylamide gel electrophoreses in the second dimension. Ampholytes (Biorad) covering the pH range 3 ± 10 were used for the isoelectric focussing. Non-speci®c proteins reacted with the antibodies used for detecting p53 protein (PAb7 and anti-sheep IgG-HRP), but were invariant in position following irradiation or phosphatase treatment. p53 protein is indicated by the arrow Figure 5 Analysis of p53 phosphoforms in BALB/c and scid kidney cells. Cells were lysed 2 h after g-irradiation (6 Gy) and immunoprecipitated p53 protein was subjected to two-dimensional gel electrophoresis. Ampholytes (BDH) used in these experiments were a 2 : 1 mix of pH ranges 4 ± 7 and 3 ± 10 respectively. The novel p53 isoforms produced in response to irradiation are indicated by the arrows one defective DNA-PK CS allele inherited from the Ovascid parent and one normal DNA-PK CS gene. We found comparable proportions of CD4
+ and CD8 + thymocytes in BALB/c (80%, 5%, 13%, 2%), Ova-scid/+ (70%, 5%, 22%, 3%) and Ova-scid/scid (48%, 23%, 23%, 6%) mice. F1 cells were previously shown to have normal radiosensitivity and to undergo immunoglobulin gene rearrangement (Fulop and Phillips, 1990) . Hence, the eect of the scid mutation on radiation sensitivity and on gene rearrangement is recessive (Fulop and Phillips, 1990) . We con®rmed that the radiation sensitivities of BALB/c and F1 thymocytes were indeed identical and dierent from that of Ova-scid thymocytes ( Figure 6 ) and that F1 but not scid thymocytes undergo normal rearrangement of the TCRd locus (data not shown).
Western immuno-blotting was performed on extracts prepared from BALB/c, F1 and Ova-scid thymocytes. Consistent with previous reports, we found that the levels of p53 protein were elevated in the Ova-scid thymocytes compared with the BALB/c thymocytes ( Figure 7a ). Comparison of BALB/c and F1 thymocytes revealed similar levels of p53 protein (Figure 7a ). The in¯uence of the scid mutation on the steady state level of p53 protein, however, was not restricted to p53; increased levels of b-tubulin and of an unknown protein that cross reacts with a GSK-3b antibody were also observed in Ova-scid thymocytes (Figure 7b ). Similar levels of GSK-3b and tau protein were detected in BALB/c and Ova-scid thymocytes indicating that the scid mutation does not cause a general increase in protein levels and con®rming that an equal amount of total protein was loaded on the gels (Figure 7a and b) .
p53 protein levels were measured in thymocytes that had been exposed to increasing doses of g-irradiation. g-irradiation of the BALB/c, Ova-scid and F1 7 BALB/c, F1 (BALB/c6Ova-scid) and Ova-scid thymocytes. Six monoclonal antibodies against p53 ± PAb122, PAb240, PAb242, PAb246, PAb248 and PAb421 ± were pooled and used to detect p53 protein. GSK-3b protein was detected using rabbit polyclonal antibody. (b) Cells were exposed to increasing doses of ionizing radiation and extracts were prepared 8 h after treatment. Western blot analysis was used to measure the levels of p53, GSK-3b, btubulin, a non-speci®c protein reacting with the GSK-3b antibody and tau protein on the same blot. Each lane represents 10 7 BALB/c (B), F1 or Ova-scid (O) thymocytes. p53 was analysed using two monoclonal antibodies, PAb122 and PAb240; b-tubulin was detected using a monoclonal antibody (Sigma) and GSK-3b and tau were detected using rabbit polyclonal antibodies. (c) a densitometric scan of the p53 data from the Western blot shown in (b) Figure 6 Viability assays of BALB/c, F1 or Ova-scid thymocytes following 2 and 5 Gy IR thymocytes resulted in p53 accumulation with the Ovascid thymocytes accumulating the most p53 protein, the BALB/c thymocytes accumulating the least amount of p53 and the F1 thymocytes accumulating an intermediate level of p53 (Figure 7b and c) . In contrast with p53, none of several other proteins examined (GSK-3b, b-tubulin, tau) accumulated in g-irradiated thymocytes regardless of scid genotype. The intermediate levels of p53 protein in the irradiated F1 thymocytes was unexpected and reveals an in¯uence of DNA-PK CS gene dosage on p53 protein accumulation. This eect cannot readily be attributed to a defect in DNA repair resulting in the accumulation of radiation-induced DNA strand breaks since the radiation sensitivities of BALB/c and F1 thymocytes were identical.
Discussion
Our results lead to three conclusions. First, we demonstrate that p53 protein undergoes phosphorylation in vivo at multiple sites in response to girradiation. We propose, therefore, that the signal transduction pathway that conveys the presence of damaged DNA to p53 operates, at least in part, through phosphorylation events. Hence, phosphorylation may represent one physiological mechanism through which p53 becomes activated in response to DNA damage. Second, the pattern of p53 phosphorylation induced by g-irradiation is similar in DNA-PK de®cient scid cells and in normal cells. Hence, DNA-PK is unlikely to be the enzyme that phosphorylates p53 in response to DNA strand breakage. Third, the abundance of p53 protein in irradiated thymocytes is in¯uenced by DNA-PK CS gene copy number.
Using 2-dimensional gel analysis, we show that p53 protein undergoes phosphorylation at multiple sites following g-irradiation. The signi®cance of these multiple phosphorylation events remains to be determined. Genetic studies in which mutations have been introduced into serine residues that are phosphorylated in vivo have led to mixed results. While some studies indicate that mutations at certain serine phosphorylation sites abolish the anti-proliferative activity of p53 (Milne et al., 1992; Fiscella et al., 1993; Hao et al., 1996) , other studies ®nd that p53 phosphorylation mutants retain transcriptional activity and growth suppression activity (Fuchs et al., 1995) . Mayr et al. (1995) reported that while mutation of individual phosphorylation sites in the amino-terminus of p53 had no eect on the suppressor function of p53, mutation of two or three serine phosphorylation sites interfered with its suppressor function.
Studies employing kinase and phosphatase inhibitors provide indirect evidence to support the functional importance of p53 phosphorylation. Khanna and Lavin (1993) for example, have shown that the accumulation of p53 protein and its function can be suppressed through the use of calphostin C, calyculin A and okadaic acid. Wortmannin, an inhibitor of PI3-kinase, prevented the accumulation of p53 protein and abrogated p53-dependent G1 arrest following girradiation (Price and Youmell, 1996) . Salicylate, an inhibitor of phosphatases, abolished p53-dependent apoptosis (Chernov and Stark, 1997) . Studies done with inhibitors of PKC led Chernov et al. (1998) to conclude that upregulation of p53 protein and its activation were dependent on independent phosphorylation events. Recent studies employing phosphospeci®c antibodies have demonstrated de novo phosphorylation of p53 at serine 15 following g-irradiation. Phosphorylation at this site was associated with disruption of MDM2 binding and with the stabilization of p53 protein (Shieh et al., 1997; Siliciano et al., 1997) . Sakaguchi et al. (1997) suggested that phosphorylation at serine 392 in¯uences the stability of p53 tetramers.
Using kidney cell cultures prepared from BALB/c and scid mice, we determined that p53 protein accumulation and cell cycle arrest occurred normally in response to g-irradiation. Moreover, the pattern of phosphorylation was similar in both cell types before and after irradiation. These results together with previous studies indicate that the activities of p53 protein involved in cell cycle arrest are not dependent on DNA-PK activity in vivo or, possibly, that DNA-PK is not the only enzyme capable of phosphorylating p53 protein.
Previous studies showed that the level of p53 protein was elevated in scid thymocytes relative to normal cells and suggested that this was due to the accumulation of double-stranded breaks in DNA resulting from failed attempts at V(D)J recombination in scid lymphocytes (Guidos et al., 1996; Nacht et al., 1996) . The persistence of DNA recombination intermediates and the high abundance of p53 protein within the same cell population suggested that p53 may be involved in the detection of abnormal recombination intermediates and in the subsequent elimination of such clones. The observation that eliminating p53 function promotes survival and partial dierentiation of defective scid or RAG 7/7 thymocytes to the CD4 + CD8 + stage of thymocyte dierentiation is consistent with a surveillance role of p53 (Guidos et al., 1996; Jiang et al., 1996) . The high incidence of lymphomas in p53-null mice is also consistent with this idea (Donehower et al., 1992; Jacks et al., 1994) . The appearance of polyploid cells in the testes of p53-null mice may be similarly related to the normal role of p53 in the surveillance of recombination intermediates in spermatocytes and the elimination of cells that undergo abnormal recombination (Rotter et al., 1993) . Our observation that the level of p53 protein is similar in BALB/c and FI (scid/+) thymocytes and is lower than that found in scid thymocytes supports the surveillance model of p53 function since the F1 cells are believed to be phenotypically normal (Fulop and Phillips, 1990) . We note, however, that this eect of DNA-PK CS is not restricted to p53 protein levels; the level of b-tubulin but not GSK-3b, was also elevated in the Ova-scid cells compared with the BALB/c cells. While the basal level of p53 protein in the BALB/c and F1 thymocytes was similar, we observed that the irradiated F1 thymocytes produced more p53 protein than the BALB/c thymocytes. Haploinsuciency at the DNA-PK CS locus results in apparently normal mice with normal lymphopoiesis. Moreover, thymocytes from F1 and BALB/c mice were equally sensitive to g-irradiation suggesting that DNA repair may not be impaired in the F1 cells. However, if DNA repair occurred more slowly in the F1 thymocytes as a result of limiting amounts of DNA-PK CS , an accumulation of damaged DNA might lead to an elevation in the level of p53. It will be of interest to compare the kinetics and eciency of DNA repair in thymocytes with one or two copies of the DNA-PK CS , gene. It is of interest to note that Fried et al. (1996) reported ®nding an association between the scid defect and increased p53 protein in mouse embryo ®broblasts before and following girradiation.
While our study shows that several phosphorylation events occur on p53 protein following irradiation, it remains important to identify the sites, the responsible kinases and the functional signi®cance of these posttranslational modi®cations.
Materials and methods

Animals and cells
BALB/c mice (H-2
d/d ) were obtained from the Jackson Laboratories (Bar Harbor, ME, USA). C.B-17 scid/scid (H-2 d/d ) were bred and maintained at the Ontario Cancer Institute (OCI) animal facility and are congenic to BALB/ c, diering only in the region of the Ig heavy chain gene (Bosma and Carroll, 1991 (Murphy et al., 1990) . This transgenic strain was obtained originally from Dr DY Loh (St. Louis, MO, USA) and has been backcrossed at least six times onto BALB/c mice in the OCI animal facility. Ova-scid mice (TCRab + scid/scid) were generated by breeding Ovamice containing the TCRab transgene to C.B.-17 scid/scid mice. F1 mice from the cross were interbred and progeny selected for the presence of the transgene and the scid phenotype. The TCR can be identi®ed with the idiotypespeci®c antibody, KJ1-26 (Shimonkevitz et al., 1984) . A high percentage of CD4 + KJ26 + peripheral blood lymphocytes in the absence of circulating B or CD8 + T cells indicated the presence of both the transgene and the scid phenotype. Ospring were developed by Caesarian section and foster-mothered under speci®c pathogen-free de®ned¯ora conditions. BALB/c mice were mated to Ovascid to produce F1 ospring (Ova-scid/+). The F1 mice are heterozygous at the DNA-PK CS locus with one defective DNA-PK CS allele inherited from the Ova-scid parent and one normal DNA-PK CS gene. The p53 7/7 mice were of a 129/SV6C57BL/6 mixed background (Jacks et al., 1994) .
Thymocytes were prepared with the use of a ®ne sieve and resuspended in a-MEM with 15% FCS. The cells were enumerated by Eosin yellow staining. The primary kidney cell cultures were prepared by mincing kidneys into tiny pieces and digesting these pieces for 10 min at 378C with Trypsin (Gibco-BRL). a-MEM with 15% Fetal Calf Serum (FCS) was added and the tissue mixture was passed several times through a 15 gauge and then through an 18 gauge needle. Heavy particles were allowed to settle for 2 min and then the cells remaining in suspension were plated in a-MEM with 15% FCS. All experiments were performed with cells before passage 8.
Immunoprecipitation
Kidney cells were washed with ice-cold Tris-buered saline containing 1 mM sodium vanadate and 100 mM sodium uoride, and immediately lysed on ice in cold modi®ed RIPA buer (150 mM NaCl, 10 mM Tris pH 7.5, 1% NP-40, 1% Triton X-100, 1% sodium deoxycholate, 0.1% SDS, 2 mg/ml aprotinin, 1 mg/ml leupeptin, 1 mg/ml pepstatin, 100 mg/ml Pefabloc (Boehringer Mannheim), 0.1 mM sodium vanadate, 50 mM sodium¯uoride and 10 mM sodium pyrophosphate). Lysates were kept on ice for 20 min, passed several times through a 25 gauge needle and centrifuged to remove insoluble debris. The protein concentration was determined by a modi®ed Lowry assay (Sigma). PAb246, a mouse p53 speci®c antibody was used to immunoprecipitate p53 protein from lysates containing 1.55 mg of total protein prepared from BALB/c, scid and p53
kidney cells. After 1 h of incubation at 48C, Gammabind Sepharose beads (Pharmacia) were added, and the lysates were incubated for a further 1 h prior to collection of the antibody-p53 complexes by centrifugation. The immune-complexes were washed three times with NET/GEL (150 mM NaCl, 5 mM EDTA, 50 mM Tris. Cl, pH 7.4, 0.05% NP-40, 0.25% gelatin) and dissociated by heating for 5 min in 16SDS sample buer.
Western blot analysis
Equal numbers of cells, either thymocytes or kidney cells, were lysed in 16SDS sample buer (2% SDS, 10% glycerol, 25 mM Tris pH 6.8, 0.1% bromophenol blue, 0.1 M dithiothreitol) or 36SDS sample buer, respectively. Lysates prepared from equal numbers of cells were loaded onto separate lanes of an SDS-10% polyacrylamide gel and subjected to electrophoresis at 45 mA. The proteins were transferred to nitrocellulose (S&S) or PVDF (NEN) membranes (Towbin et al., 1979) for subsequent immunoblotting with antibodies against p53 (PAb7, Oncogene Science), GSK-3b, tau, and b-tubulin (Sigma). Chemiluminescence (NEN) was used to detect membrane-bound antibody.
Thymocyte viability assays 10 6 thymocytes were placed in 96 well plates in a volume of 200 ml a-MEM containing 15% FCS. Cells were girradiated at doses of 2, 5 or 10 Gy. Control cells were not irradiated. Viable cells were enumerated on the basis of eosin yellow exclusion. The mean number of viable cells at each time point and at each radiation dose was derived from quadruplicate counts.
Cell cycle analysis
Three610
5 cells were plated on 10 cm plates and irradiated on the following day. Twenty-four hours after irradiation, cells were lysed in 1 ml isotonic buer (0.2% Triton X-100 in PBS citrate, 0.1 mg/ml RNase A, 0.05 mg/ml propidium iodide) to release the nuclei and the extract was strained through a ®ne mesh to remove cell debris. Following a 30 min incubation at 48C in the dark, the samples were analysed on a Becton-Dickenson¯ow cytometer. A cell cycle analysis program, SOBR, was used to quantify cells in the dierent phases of the cell cycle.
Two-dimensional gel electrophoresis
Two-dimensional gel electrophoresis was carried out by the method of O'Farrell as described by Adams and Gallagher (1995) with minor modi®cations. p53 protein was immunoprecipitated from cell extracts containing approximately 4 mg of protein. Phosphatase reactions were carried out at 308C for 30 min, in the buer speci®ed by the supplier (50 mM Tris.Cl, pH 7.8, 5 mM DTT, 2 mM MnCl 2 and 0.1 mg/ml BSA) with 500 units l-protein phosphatase (NEB) in a 0.2 ml reaction. The washed immune-complexes were solubilized in modi®ed SDS lysis buer (1% CHES, 2% SDS, 2% Triton X-100, 1% DTT, 10% glycerol). Isoelectric focusing tube gels contained single ampholytes (pH 3 ± 10) or ampholytes (pH 4 ± 8 and pH 3 ± 10) mixed in a 2 : 1 ratio. The gels were prefocused for 1 h at 200 volts. The samples were loaded and overlayed to protect against the alkali in the upper reservoir buer (0.02 M NaOH). The lower reservoir buer consisted of 0.085% H 3 PO 4 . Proteins were resolved by isoelectric focusing in the ®rst dimension at a constant voltage of 800 volts for 16 h. The gels were extruded with water pressure and stored frozen at 7708C. The focused gels were incubated for 10 min in 16SDS sample buer, loaded on top of a 9.5% polyacrylamide gel containing SDS. Following electrophoresis, the protein gel was subjected to Western blotting as described previously.
